490 related articles for article (PubMed ID: 32899957)
21. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects.
Rocchi A; Orsucci D; Tognoni G; Ceravolo R; Siciliano G
Curr Alzheimer Res; 2009 Jun; 6(3):224-37. PubMed ID: 19519304
[TBL] [Abstract][Full Text] [Related]
22. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
[TBL] [Abstract][Full Text] [Related]
23. Systemic and central nervous system metabolic alterations in Alzheimer's disease.
van der Velpen V; Teav T; Gallart-Ayala H; Mehl F; Konz I; Clark C; Oikonomidi A; Peyratout G; Henry H; Delorenzi M; Ivanisevic J; Popp J
Alzheimers Res Ther; 2019 Nov; 11(1):93. PubMed ID: 31779690
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
25. The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence.
Kosenko E; Tikhonova L; Alilova G; Urios A; Montoliu C
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31940879
[TBL] [Abstract][Full Text] [Related]
26. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
27. The Role of Irisin in Alzheimer's Disease.
Kim OY; Song J
J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30388754
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
VanItallie TB
Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
[TBL] [Abstract][Full Text] [Related]
29. Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.
Chakrabarti S; Khemka VK; Banerjee A; Chatterjee G; Ganguly A; Biswas A
Aging Dis; 2015 Aug; 6(4):282-99. PubMed ID: 26236550
[TBL] [Abstract][Full Text] [Related]
30. Genes and susceptible loci of Alzheimer's disease.
Shastry BS; Giblin FJ
Brain Res Bull; 1999 Jan; 48(2):121-7. PubMed ID: 10230703
[TBL] [Abstract][Full Text] [Related]
31. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.
Martins IJ; Hone E; Foster JK; Sünram-Lea SI; Gnjec A; Fuller SJ; Nolan D; Gandy SE; Martins RN
Mol Psychiatry; 2006 Aug; 11(8):721-36. PubMed ID: 16786033
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
Poirier J
Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
[TBL] [Abstract][Full Text] [Related]
34. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
Duarte AI; Santos MS; Oliveira CR; Moreira PI
Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
[TBL] [Abstract][Full Text] [Related]
35. Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.
Kosenko EA; Tikhonova LA; Montoliu C; Barreto GE; Aliev G; Kaminsky YG
Front Neurosci; 2017; 11():728. PubMed ID: 29354027
[TBL] [Abstract][Full Text] [Related]
36. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for Alzheimer's disease.
A Armstrong R
Folia Neuropathol; 2019; 57(2):87-105. PubMed ID: 31556570
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetics of Alzheimer's disease and aging.
Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
[TBL] [Abstract][Full Text] [Related]
39. Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease.
Harris SA; Harris EA
Front Aging Neurosci; 2018; 10():48. PubMed ID: 29559905
[TBL] [Abstract][Full Text] [Related]
40. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
